Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.340
-0.265 (-16.51%)
At close: Nov 12, 2026, 4:00 PM EST
1.280
-0.060 (-4.48%)
After-hours: Nov 12, 2026, 7:59 PM EST
Fate Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Cantor Fitzgerald No rating | Cantor Fitzgerald | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Nov 11, 2026 |
| Wedbush | Wedbush | Buy Reiterates $7 | Buy | Reiterates | $7 | +422.39% | Nov 6, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $8 | Buy | Reiterates | $8 | +497.01% | Nov 6, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $3.5 → $3 | Hold | Reiterates | $3.5 → $3 | +123.88% | Nov 6, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $2.2 → $2.5 | Hold | Reiterates | $2.2 → $2.5 | +86.57% | Nov 6, 2026 |
| Needham | Needham | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Oct 5, 2026 |
Unknown Analyst Mizuho Securities No rating | Mizuho Securities | Buy Maintains $8 | Buy | Maintains | $8 | +497.01% | Aug 17, 2026 |
| TD Cowen | TD Cowen | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.